Physician profile
Thomas J Kirisits
NPI 1053352005
$8,660.95
in general payments reported to CMS, 2019-2025
13 companies · $74.45 in 2025
The $74.45 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,573 · 2020: $1,282 · 2021: $2,800 · 2022: $1,271 · 2023: $92.03 · 2024: $570 · 2025: $74.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $7,221.11 | 2019-2025 | |
| Organogenesis INC. | $673.91 | 2019-2024 | |
| Kerecis Limited | $161.13 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Medtronic, INC. | $129.20 | 2024 | Intellis Adaptivestim |
| Heron Therapeutics, INC. | $125.00 | 2021 | |
| Integra Lifesciences Corporation | $120.27 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $117.90 | 2020-2024 | Easy Clip, Easyfuse |
| Smith+Nephew, INC. | $32.40 | 2019-2024 | Grafix Pl |
| Misonix INC | $22.67 | 2019 | |
| Wright Medical Technology, INC. | $18.09 | 2019 | |
| Solventum Corporation | $15.61 | 2024 | V.A.C.Instill |
| Paragon 28, INC. | $15.26 | 2021 | |
| Orthofix Medical, INC. | $8.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kirisits listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.